General Manager – Uro-Oncology and WMS TheatresNHS

Job summary

An exciting opportunity has arisen in the Surgical Specialties Division at University College London Hospital NHS Foundation Trust, for a General Manager covering Uro-Oncology and Westmoreland Street Theatres.

We are looking for a dynamic leader, who is passionate about quality, patient-centred care, and our people. You will work closely with and lead the Urology Oncology team and WMS theatres as well as working cross division to support the operational running of the department.

This is a fantastic development opportunity for an individual looking to gain further experience in a large, complex tertiary cancer service. Candidates will require the ability to manage competing demands across several complex services, whilst being adaptable to the strategic and operational needs of the division.

Main duties of the job

The Uro-Oncology and WMS Theatres General Manager is an exciting role, providing key operational and strategic leadership across a large, world-leading urological cancer service and 7 operating theatres. The role is pivotal to the successful running of theatres at Westmoreland Street and for urology cancer performance.

This is a dynamic leadership role focused on improving cancer waiting times, optimising theatre productivity, ensuring financial efficiency, leading teams, and supporting innovation at Westmoreland Street. The successful candidate will work in close partnership with clinical and operational teams to lead on performance, optimise productivity, reduce waits, and deliver high-quality patient care in a complex surgical environment.This post holder will also have operational responsibility for the WMS site as manager of the day, leading EPRR events and supporting staff and patient with incident management.

We are seeking a proactive and analytical individual with a passion for operational excellence and a collaborative approach to leadership.

Job description

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

Come and be a part of the best NHS trust in England to work for, according to our staff*

• UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England for the third year in a row.

UCLH recognises the benefits of flexible working for staff To find out more, visit: Flexible working.

To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?

About us

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.

We provide first-class acute and specialist services across eight sites:o University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)o National Hospital for Neurology and Neurosurgeryo Royal National ENT and Eastman Dental Hospitalso University College Hospital Grafton Way Buildingo Royal London Hospital for Integrated Medicineo University College Hospital Macmillan Cancer Centreo The Hospital for Tropical Diseaseso University College Hospital at Westmoreland Street

We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.